EOJOAM
LEGN icon

E. Ohman J:or Asset Management’s Legend Biotech LEGN Stock Holding History

E. Ohman J:or Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,600
Closed -$370K – 428
2024
Q1 		$370K Hold
6,600
– – 0.01% 385
2023
Q4 		$397K Sell
6,600
-1,700
-20% -$108K 0.01% 363
2023
Q3 		$558K Sell
8,300
-1,700
-17% -$118K 0.02% 334
2023
Q2 		$690K Hold
10,000
– – 0.02% 310
2023
Q1 		$482K Buy
+10,000
New +$489K 0.02% 360

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

E. Ohman J:or Asset Management's LEGN Position: Q2 2024 in Review

E. Ohman J:or Asset Management sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 6,600 shares — an estimated $370K sold.

E. Ohman J:or Asset Management first reported a position in LEGN in Q1 2023 and held it in 5 quarters. The position peaked at $690K in Q2 2023. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • E. Ohman J:or Asset Management reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • E. Ohman J:or Asset Management sold 6,600 Legend Biotech shares in Q2 2024, an estimated $370K.
  • E. Ohman J:or Asset Management first reported a position in Legend Biotech in Q1 2023 and held it in 5 quarters.
  • E. Ohman J:or Asset Management's Legend Biotech position peaked at $690K in Q2 2023.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.